Market closedADR

Silence Therapeutics/$SLN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Silence Therapeutics

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Ticker

$SLN
Trading on

Industry

Biotechnology

Employees

116

ISIN

US82686Q1013

SLN Metrics

BasicAdvanced
$168M
-
-$1.52
-
-
$168M
$5.28
$1.97
281K
8.814
7.962
0.053
-106.17%
6.049
1.49
1.64
-2.359
-16.00%
36.07%
12.66%
-3.10%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SLN

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Silence Therapeutics stock?

What is the P/E ratio for Silence Therapeutics stock?

Does Silence Therapeutics stock pay dividends?

When is the next Silence Therapeutics dividend payment date?

What is the beta indicator for Silence Therapeutics?